GEMCITABINE AND S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED STAGE OF PANCREATIC CANCER

被引：0
|
作者：
Ouchi, J. [1 ]
Hijioka, M. [1 ]
Harada, S. [1 ]
Maruyama, Y. [1 ]
Funakoshi, A. [1 ]
机构：
[1] Kyushu Natl Canc Ctr, Dept Gastroenterol, Fukuoka, Japan
来源：
PANCREAS | 2008年 / 37卷 / 04期
关键词：
D O I：
10.1097/01.MPA.0000335356.63524.1b
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：488 / 488
页数：1
相关论文
共 50 条
  • [21] A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Ishiguro, Y
    Morizane, C
    Matsubara, J
    Furuse, J
    Ishii, H
    Nagase, M
    Nakachi, K
    ONCOLOGY, 2005, 69 (05) : 421 - 427
  • [22] Multicenter Phase II Study of Gemcitabine and S-1 Combination Therapy (GS Therapy) in Patients With Metastatic Pancreatic Cancer
    Ueno, Hideki
    Okusaka, Takuji
    Furuse, Junji
    Yamao, Kenji
    Funakoshi, Akihiro
    Boku, Narikazu
    Ohkawa, Shinichi
    Yokosuka, Osamu
    Tanaka, Katsuaki
    Moriyasu, Fuminori
    Nakamori, Shoji
    Sato, Tosiya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 953 - 958
  • [23] A multicenter phase II study of gemcitabine and S-1 combination therapy (GS therapy) in patients with metastatic pancreatic cancer
    Ueno, H.
    Okusaka, T.
    Furuse, J.
    Yamao, K.
    Funakoshi, A.
    Boku, N.
    Ohkawa, S.
    Makimoto, A.
    Sato, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer
    Han, Boram
    Kim, Bum Jun
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoung Yong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Song, Hunho
    Kim, Jong Hyeok
    Park, Choong Kee
    Lee, Jung Woo
    Kim, Min-Jeong
    Zang, Dae Young
    JOURNAL OF CANCER, 2021, 12 (03): : 912 - 917
  • [25] A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
    Nakai, Y.
    Isayama, H.
    Sasaki, T.
    Sasahira, N.
    Tsujino, T.
    Toda, N.
    Kogure, H.
    Matsubara, S.
    Ito, Y.
    Togawa, O.
    Arizumi, T.
    Hirano, K.
    Tada, M.
    Omata, M.
    Koike, K.
    BRITISH JOURNAL OF CANCER, 2012, 106 (12) : 1934 - 1939
  • [26] A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
    Y Nakai
    H Isayama
    T Sasaki
    N Sasahira
    T Tsujino
    N Toda
    H Kogure
    S Matsubara
    Y Ito
    O Togawa
    T Arizumi
    K Hirano
    M Tada
    M Omata
    K Koike
    British Journal of Cancer, 2012, 106 : 1934 - 1939
  • [27] Neoadjuvant Chemotherapy With Gemcitabine and S-1 for Locally Advanced Pancreatic Cancer
    Kin, T.
    Maguchi, H.
    Takahashi, K.
    Katanuma, A.
    Osanai, M.
    Yane, K.
    Ikarashi, S.
    Sen-yo, M.
    Minami, R.
    Sano, I.
    PANCREAS, 2014, 43 (08) : 1379 - 1379
  • [28] S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer: A meta-analysis (PRISMA) of randomized control trials
    Zhong, Sheng
    Qie, Shuai
    Yang, Liu
    Yan, Qi
    Ge, Linna
    Wang, Zhongfeng
    MEDICINE, 2017, 96 (30)
  • [29] Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer
    Kentaro Sudo
    Taketo Yamaguchi
    Kazuyoshi Nakamura
    Tadamichi Denda
    Taro Hara
    Takeshi Ishihara
    Osamu Yokosuka
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 249 - 254
  • [30] S-1 and Gemcitabine as an Outpatient-based Regimen in Patients with Advanced or Metastatic Pancreatic Cancer
    Kim, Min Kyoung
    Lee, Kyung Hee
    Jang, Byung Ik
    Kim, Tae Nyeun
    Eun, Jong Ryul
    Bae, Sung Hwa
    Ryoo, Hun Mo
    Lee, Sun Ah
    Hyun, Myung Soo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (01) : 49 - 53
12345